USPTO serial 98701836
REGENATS
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- REID, MONICA R
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with REGENATS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $772*
Plus Government fees of $375
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Jersey City, NJ, US
Jersey City, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lindsay H. Kaplan
Lindsay H. Kaplan L. Kaplan LawP.O. Box 4062Kingston, NY 12402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetics, namely, beauty masks, cosmetic kits comprising primarily of lotions, creams, and preparations for skin care, cosmetic creams, lotions for cosmetic purposes, cosmetic lotions, cosmetic preparations for skin care, pomades for cosmetic purposes, tissues impregnated with cosmetic lotions, cotton buds for cosmetic purposes, cosmetic kits for skin care comprising primarily of lotions, creams, and preparations for skin care, non-medicated preparations for skin care, namely, skin serum not for medical use, skin care preparations, namely, non-medicated skin serum, non-medicated stimulating lotions for the skin, anti-wrinkle cream for skin care, non-medicated anti-aging serum; non-medicated hyaluronic acid skin care preparations; non-medicated silk skin care preparations; Socks impregnated with moisturizing preparations for the feet, namely, hyaluronic acid, silk, platelet rich plasma, platelet rich fibrin, or any combination thereof; Facial sheet mask for cosmetic use impregnated with thrombin, hyaluronic acid, silk, platelet rich plasma, platelet rich fibrin, or any combination thereof; Gel eye mask impregnated with hyaluronic acid, silk, platelet rich plasma, platelet rich fibrin, or any combination thereof. | ACTIVE | — |
| 005 | Biological preparations for medical use for the treatment of damaged skin or tissue, namely, thrombin, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, chitosan, silk or any combinations thereof; Pharmaceutical preparations, namely, solutions for application on skin tissue for the purpose of promoting cellular regeneration; pharmaceutical skin lotions; tissues impregnated with pharmaceutical lotions for the treatment of damaged skin or tissue; medicated skin care preparations; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; preparations for medical purposes for cleaning the skin; cells for medical or clinical purposes. | ACTIVE | — |
| 010 | Medical devices, namely, kits comprising blood collection tubes, drug administration tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, syringes, needles, holders, gels, connectors, tourniquets, plaster, pads, masks, pliers, creams, spatulas, flasks, discs, dispensers, nozzles, stoppers, adapters, cannulas, transfer devices, ampoules, backstops, anticoagulants, coagulation activators, hyaluronic acid, silk and chitosan, intended for the preparation of thrombin, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, or any combinations thereof, sold as a unit; Medical apparatus and instruments for use in cosmetics, esthetics, facial, face-lift and plastic surgery; syringes for injections; receptacles for applying medicines, namely, cannulae, syringes for injections, tubes for use with cannulas, infusion and injection devices for administering drugs, thrombin, platelet-rich plasma, hyaluronic acid, chitosan, silk-proteins and hydrogels; medical injection instruments in the nature of injection device for pharmaceutics; medical instruments, namely, surgical instruments for facilitating the identification, separation or removal of biological tissue; medical apparatus used for taking blood; medical apparatus used for separating blood components for medical purposes; medical instruments used for filtering blood and blood components; medical apparatus used for introducing pharmaceutical preparations into the human body; medical apparatus for the preparation of platelet concentrate, glycosaminoglycan and polysaccharide hydrogels. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 5, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| May 5, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 4, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 4, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 4, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 4, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 8, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 13, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 13, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 13, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 13, 2025 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jun 13, 2025 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jun 13, 2025 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jun 13, 2025 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 13, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 24, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 24, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 24, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 17, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 16, 2024 | NWAP | NEW APPLICATION ENTERED | — |